Not recommended for individuals taking certain medications such as digoxin or thiazide diuretics without medical clearance
A recent review that examined the efficacy, safety, and perspective for the future of the once-weekly GLP-1 receptor agonists exenatide, taspoglutide, albiglutide, LY2189265 and CJC-1134-PC, and compared them to the currently available agonists, exenatide BID and liraglutide QD, concluded that the long-acting agonists are not superior compared to the currently used exenatide BID and liraglutide QD regarding weight loss (127).In a separate development, an orally administered PYY3-36 and GLP-1 combination has been formulated using a sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) carrier (127)
Reviewed by a Canadian pharmacist
Korzyci z GHK-Cu udokumentowane w literaturze naukowej obejmuj niezwykle szerokie spektrum
Hi there, I have a question about my new weight loss medication
doi: 10.3945/ajcn.2009.27493 56 LiJKangXZhangLLuoJZhangD